Planning for Bone Excision in Ewing Sarcoma | Zendy

Camille Thévenin-Lemoine | Zendy; Louise Destombes | Zendy; Julie Vial | Zendy; Matthieu Wargny | Zendy; P. Bonnevialle | Zendy; Yan Lefèvre | Zendy; A. Brouchet | Zendy; Jérôme Sales de Gauzy | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Planning for Bone Excision in Ewing Sarcoma

Author(s) -

Camille Thévenin-Lemoine,

Louise Destombes,

Julie Vial,

Matthieu Wargny,

P. Bonnevialle,

Yan Lefèvre,

A. Brouchet,

Jérôme Sales de Gauzy

Publication year - 2018

Publication title -

journal of bone and joint surgery

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.634

H-Index - 260

eISSN - 1058-2436

pISSN - 0021-9355

DOI - 10.2106/jbjs.16.01461

Subject(s) - medicine , sarcoma , magnetic resonance imaging , chemotherapy , interquartile range , radiology , osteosarcoma , humerus , nuclear medicine , surgery , pathology

In determining the level of bone resection in Ewing sarcoma, the most suitable time at which to perform magnetic resonance imaging (MRI) remains controversial. Current guidelines recommend that surgical planning be based on MRI performed prior to neoadjuvant chemotherapy. The goal of this study was to determine whether pre-chemotherapy or post-chemotherapy MRI provides greater accuracy of tumor limits for planning bone excision in the management of Ewing sarcoma.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research